Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Dermatology
Myositis
Questions discussed in this category
How do you go about switching from one DMARD to another In patients with dermatomyositis that remains active?
Do you taper one DMARD as you uptitrate another versus do you stop the first DMARD and quickly uptitrate another one?
1 Answer available
How will you sequence therapies in dermatomyositis given the results of the ProDERM trial?
Will you still favor starting with steroids and traditional immunosuppressive agents, move IVIG earlier in your treatment strategy, or start with IVIG...
3 Answers available
Is a biopsy of either skin or muscle always indicated in the diagnosis of dermatomyositis?
1 Answer available
How do you screen dermatomyositis patients for malignancy if they have a high risk antibody profile (NXP-2/TIF1gamma positive) and their initial screen is negative?
1 Answer available
Would you avoid combining JAK inhibitors with IVIG given the risk of thromboembolism?
4 Answers available
What's the best approach for severe calcinosis cutis in a patient with dermatomyositis who is unresponsive to diltiazem and colchicine?
6 Answers available
How do you recommend tapering IVIG in patients whose inflammatory myositis has achieved remission?
4 Answers available
Which myositis patients are good candidates for IVIG?
3 Answers available
How long can you treat dermatomyositis with IVIG?
3 Answers available
Do you screen for interstitial lung disease in patients with newly diagnosed polymyositis or dermatomyositis in the absence of respiratory symptoms?
3 Answers available
Do you feel comfortable using azathioprine for dermatomyositis in patients with cirrhosis?
For example, in the setting of cirrhosis incidentally found on imaging.
2 Answers available
How would you manage subclinical ILD associated with MDA-5 Dermatomyositis?
Any indications for triple therapy in the patients with subclinical ILD associated with MDA-5 dermatomyositis?
1 Answer available
How do you manage anti-Mi-2 positive dermatomyositis with predominantly cutaneous manifestations?
1 Answer available
What therapies have you had the most success with for calcinosis cutis in dermatomyositis patients?
1 Answer available
What would be your next step in management of a dermatomyositis patient on hydroxychloroquine and methotrexate whose skin is still active?
Muscle disease is quiescent and no other manifestations such as ILD
1 Answer available
What is your first treatment of choice in patients with dermatomyositis sine myositis?
1 Answer available
19387
16803
11657
8117
16802
16925
15108
7319
16647
14483
12730
13629
12691
9530
9529
7317
Papers discussed in this category
,
Systemic Treatment for Clinically Amyopathic Dermatomyositis at 4 Tertiary Care Centers.
, 2016 Aug 30
Treatment of clinically amyopathic dermatomyositis in adults: a systematic review.
N Engl J Med, 2022 Oct 06
Trial of Intravenous Immune Globulin in Dermatomyositis.
Minerva Gastroenterol Dietol, 2016 Sep 07
Glutathione in the treatment of liver diseases: insights from clinical practice.
Free Radic Biol Med,
Effect of liver cirrhosis and age on the glutathione concentration in the plasma, erythrocytes, and gastric mucosa of man.
The New England journal of medicine, 1993-12-30
A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis.
J Rheumatol, 2022 May 15
Management of Calcinosis Cutis in Rheumatic Diseases.
Related Topics in Dermatology
Lung Cancer
Breast Cancer
Head and Neck Cancers
Hematologic Malignancies
Radiation Oncology
Gynecologic Cancers
Palliation
Gastrointestinal Cancers
Genitourinary Cancers
Melanoma/Skin Cancer